Gilead Sciences, Inc. · GILD
As of the latest run, Gilead Sciences, Inc. (GILD) scores 66/100 overall — a broadly solid profile. Its strongest dimension: profitability (100/100); the one that most warrants attention: risk control (18/100).
Three pillars judge the company (profitability, growth, financial health), three judge the stock (valuation, momentum, risk). The score is recomputed every day from Yahoo Finance market data — the one shown above reflects today's state.
Profitability comes in at 100/100 — above-average margins and return on capital. Financial health comes in at 100/100 — a solid balance sheet, with controlled debt and sufficient liquidity. Growth comes in at 83/100 — sustained revenue growth.
The breakdown of each pillar — and a plain-English explanation of what it measures — is available in the full analysis, free and updated every day.
The risk pillar falls to 18/100 — high volatility — the stock swings hard, both ways. Valuation falls to 44/100 — a stretched price relative to the stock's own valuation history.
No score replaces your own judgment: Stock Analyzer is a tool for analysis and understanding, not investment advice.